Kalaris Therapeutics, Inc. (KLRS): 10-Q filed Aug 11, 2026

Form type

10-Q

Filing date

Aug 11, 2026

Accession number

0001193125-26-344532

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)